A recent study has shown a decline in testosterone prescriptions since media reports of potential increased cardiovascular risk in 2014. The phenomenon of medical hysteria accounts for this reduced prescribing, as numerous subsequent studies provide substantial evidence of reduced cardiovascular risk and other important benefits with testosterone therapy for men with testosterone deficiency.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Traish, A. M., Vance, J. C. & Morgentaler, A. Overselling hysteria: the role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy. EMBO Rep. 18, 11–17 (2017).
Vigen, R. et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310, 1829–1836 (2013); erratum 311, 967 (2014).
Baillargeon, J. et al. Testosterone prescribing in the United States, 2002-2016. JAMA. 320, 200–202 (2018).
Morgentaler, A. et al. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin. Proc. 90, 224–251 (2015).
Traish, A. M., Guay, A. T. & Morgentaler, A. Death by testosterone? We think not! J. Sex. Med. 11, 624–629 (2014).
Morgentaler, A. & Lunenfeld, B. Testosterone and cardiovascular risk: world’s experts take unprecedented action to correct misinformation. Aging Male 17, 63–65 (2014).
Miner, M. et al. The state of testosterone therapy since the FDA’s 2015 labelling changes: indications and cardiovascular risk. Clin. Endocrinol. (Oxf.). 89, 3–10 (2018).
US Food and Drug Administration. http://www.fda.gov/fdac/departs/196_upd.html (Accessed 6 March 2007).
Baillargeon, J. et al. Screening and monitoring in men prescribed testosterone therapy in the U. S., 2001–2010. Publ. Health Rep. 130, 143–152 (2015).
Morgentaler, A. et al. Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clin. Proc. 9, 881–896 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.M. has received payments from Acerus for lecture honoraria, Aytu for consulting, and Endo for research grants.
Rights and permissions
About this article
Cite this article
Morgentaler, A. Testosterone therapy and medical hysteria. Nat Rev Urol 15, 659–660 (2018). https://doi.org/10.1038/s41585-018-0081-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-018-0081-2